期刊文献+

4种头孢菌素对社区呼吸道感染分离菌的体外抗菌活性 被引量:3

In Vitro antibacterial activity of 4 kinds cephalosporins against clinical isolated from community aquired respiratory tract infections
暂未订购
导出
摘要 目的研究头孢菌素的体外抗菌活性。方法从未接受抗菌药物治疗或48h接受有效抗菌药物治疗的呼吸道感染病人中分离致病菌,采用纸片法测定细菌敏感试验结果及采用琼脂平板二倍稀释法测定最低抑菌浓度(MIC)。结果本项研究共分离出致病菌160株,常见病原菌为:克雷伯菌(42)、嗜血杆菌(30)、葡萄球菌(30)、肺炎链球菌(9)、阴沟肠杆菌(7)和大肠埃希菌 (14)。对于流感嗜血杆菌和肺炎链球菌头孢呋辛和头孢他啶的敏感性为100%;对于甲氧西林敏感的金黄色葡萄球菌(MSSA)头孢唑林钠的敏感性最高,为100%,其次为头孢呋辛94%、头孢他啶61%,其MIC值的结果显示同样的结果;对于革兰阴性杆菌,第三代头孢菌素最强,依次为第二代、一代头孢菌素,在本次实验中一代头孢菌素对于克雷伯菌、大肠埃希菌有较好的抗菌活性。结论针对不同来源的病人,合理选择不同的头孢菌素。 Objective The antibacterial activity in vitro of Cephalosporin was evaluated. Methods Bacteria isolated from respiratory tract infection patients who had not received antibacterial drug treatment or 48 hours utility treat- ment. In-vitro activity of bacteria isolates to 4 antibioties by kirby-Bauer method and minimal inhibitory con- centrations(MIC)were measured by agar dilution method.Results 160 strains bacteria isolates from respi- ratory tract infection: Klebsiella spp(42), Haemophilus spp(30), Staphylococcus(30), S.pneumoniae (9), Enterobacter cloacae(7) and Escherichia coli(14). The sensibitity of Cefuroxime and Cefatazidime to Haemophilus spp. and Streptococcal pneumoniae was more than 90%; To MSSA Cefazolin was most high 100%, Cefuroxime 94%, Cefatazidime 61%, their MIC were similar; To gram negative bacilli bacteria, in vitro antibacterial activity of Cefatazidime was the best, in order was Cefuroxime, Cefazolin and Cefalexin; Cefazolin and Cefalexin against Klebsiella spp,Escherichia coli showed a high susceptibility.Conclusion Cephalosporin should be used reasonable to various source bacterial infection.
机构地区 卫生部北京医院
出处 《临床药物治疗杂志》 2004年第6期38-41,共4页 Clinical Medication Journal
  • 相关文献

参考文献3

  • 1[1]National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. 12th informational supplement. NCCLS,2002, M100~ S12
  • 2[2]Sharp Susan E. Commensal and pathogenic microorganisms of humans. Manual of clinical microbiology. Washington D.C: ASM Press, 1999, 7th: 25~ 26
  • 3胡云建,许宏涛,艾晓曼,宣天芝,陈东科,张秀珍.重症监护病房革兰阴性杆菌对常用抗菌药物体外抗菌活性研究[J].中国临床药理学杂志,2002,18(3):177-181. 被引量:4

二级参考文献5

共引文献3

同被引文献10

  • 1周云芳,梁铁美,邹晓华,陈文钦.头孢哌酮舒巴坦与头孢他啶治疗下呼吸道感染的疗效比较[J].中国药师,2004,7(8):628-629. 被引量:12
  • 2陈文彬,梁宗安,程德云.特美汀治疗慢性阻塞性肺病和肺心病下呼吸道感染的疗效观察[J].中国实用内科杂志,1995,15(2):96-97. 被引量:14
  • 3National Committee for Clinical Laboratory Standards . Performance standards for antimicrobial susceptibility testing; 13th informational supplement[ S]. NCCLS,M100 - S15,2005:32 -69.
  • 4Clinical and Laboratory Standards Institute. Methods for anfimicrobial and disk susceptibility testing of infrequently isolated or fastidious bacteria [ A ]. Approved Guideline [ M ]. CLSI, M45 - A. 2007 : 28.
  • 5Koch E, Wiemann H, Empl I. Cefazedone - results of a muhicentre clinical test ( author's transl ) [ J ]. MMW Munch Med Wochenschr, 1980 ; 122:431 - 434.
  • 6Schneiderhan H, Buchegger G. The treatment of bacterial respiratory and urinary tract infections with cefazedone. Clinical proof of effectiveness and tolerance [ J ]. Fortschr Med, 1981 ; 99:435 - 438.
  • 7Adamek L, Mayer F, Wolf R,et al. Use of preventive intra- operative antibiotic administration in appendectomy. A pharmacokinetic study [J]. Zentralbl Chir, 1991;116:801 -808.
  • 8Blum J,Schwarz M,Voth D.Antibiotic single-dose prophylaxis of shunt infections.Neurosurg Rev,1989,12(3):239-244.
  • 9沈伟,马朝,刘静,史瑞娜,曹永孝.头孢西酮钠对临床分离细菌感染小鼠的保护作用[J].中国实用医药,2008,3(1):17-19. 被引量:2
  • 10胡云建,林澜,艾效曼,葛庚芝,宣天芝,刘颖,孙自镛,闫东辉.头孢西酮钠的体外抗菌活性[J].中国临床药理学杂志,2008,24(3):225-229. 被引量:7

引证文献3

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部